Centre asks Serum Institute, Bharat Biotech to lower prices of Covishield, Covaxin: Sources
Govt rejects Serum Institute of India’s request to export 50 lakh doses of Covishield vaccine to UK
Amid reports of Covid-19 vaccine shortage across the country, the Modi government has refused to allow Serum Institute of India (SII) to export around 50 lakh doses of Covishield vaccine to the United Kingdom. While rejecting SII’s request, the central government insisted that the local vaccine production be supplied to protect Indians first.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Govt rejects Serum Institute of India’s request to export 50 lakh doses of Covishield vaccine to UKBy The Economic Times| 245 views
Covishield Price Drop : Serum Institute ने कोविशील्ड का घटाया दाम, 300 में मिलेगी कोरोना की वैक्सीन
Serum Institute ने कोविशील्ड का घटाया दाम, राज्यों को अब 300 में मिलेगी कोरोना की वैक्सीन
Visit Us - http://www.inhnews.in/
Follow Us On Twitter - https://twitter.com/inhnewsindia
Our WhatsApp Number - 9993022843
Link - https://youtu.be/XVOd1wWkhx8
Incoming Search Terms,
#COVIDSecondWave #CoronavirusVaccine
COVID-19 Vaccine News,
Corona Vaccine,
Covid-19 vaccination,
Corona Vaccine In India,
COVID-19 Vaccine in India,
COVID-19 vaccination in India,
COVID Second Wave in India,
Corona Second Wave,
Corona Virus Outbreak in India,
Corona Virus in India,
Latest News,
Covishield Price Drop : Serum Institute ने कोविशील्ड का घटाया दाम, 300 में मिलेगी कोरोना की वैक्सीनBy Inh News| 136 views
Serum fixes 'Covishield' prices at Rs 400 per dose for state govts, Rs 600 for private hospitals
Serum Institute of India (SII), the world's largest vaccine maker, on Wednesday announced a price of Rs 600 per dose for COVID vaccine supplies to private hospitals and Rs 400 per dose to state governments. In a statement posted on its Twitter handle, SII said it will address the limited capacity by scaling up the vaccine production over the next two months.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Serum fixes 'Covishield' prices at Rs 400 per dose for state govts, Rs 600 for private hospitalsBy The Economic Times| 453 views
Coronavirus : कोरोनावायरस की तीसरी लहर से Bharat Biotech की 'Covaxin' बचाएगी बच्चों को !
कोरोनावायरस : भारत में कोरोनावायरस संक्रमण की तीसरी लहर इस साल सर्दियों के मौसम यानी नवंबर के अंत और दिसंबर की शुरुआत में आने की संभावना है। हेल्थ एक्सपर्ट्स का कहना है कि यह तीसरी लहर बच्चों के लिए ज़्यादा खतरनाक होगी। इस खबर ने पेरेंट्स की चिंता को बढ़ा दिया था क्योंकि देश में बच्चों के लिए कोरोना वायरस की कोई वैक्सीन अभी उपलब्ध नहीं है। लेकिन इस बीच बड़ी खुशखबरी ये मिल रही है कि जल्द ही 2 साल से 18 साल तक के बच्चों के लिए आने वाले दिन में कोरोना की वैक्सीन मिल सकती है। भारत बायोटेक की कोवैक्सीन जल्द ही बच्चों के लिए भी उपलब्ध हो जाएगी। आधिकारिक सूत्रों ने कहा है कि मंगलवार को सेंट्रल ड्रग्स स्टैंडर्ड कंट्रोल आर्गेनाईजेशन यानी (CDSCO ) की एक विशेष पैनल ने भारत बायोटेक की कोवाक्सिन को 2 से 18 साल की उम्र के ट्रायल के लिए मंजूरी दे दी है। यह ट्रायल विभिन्न जगहों पर 525 बच्चों पर होगा, जिनमें एम्स दिल्ली, एम्स पटना और मेडिट्रिना इंस्टीट्यूट ऑफ मेडिकल साइंसेज, नागपुर शामिल हैं। कोवैक्सीन पूरी तरह से स्वदेशी है, जिसे भारत बायोटेक ने बनाया है। अभी तक यह वैक्सीन 18 साल से ऊपर से लोगों के लिए ही बनाई गई है।
To Subscribe on Youtube:
https://www.youtube.com/user/punjabkesaritv
Follow us on Twitter :
https://twitter.com/punjabkesari
Like us on FB:
https://www.facebook.com/Pkesarionline/
Coronavirus : कोरोनावायरस की तीसरी लहर से Bharat Biotech की 'Covaxin' बचाएगी बच्चों को !By PunjabKesari TV| 375 views
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch News
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch News
Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently and has been developed by Bharat Biotech.
#BharatBiotech #Covaxin #CovidVaccine #catchnews #CatchNewsToday
For more videos, subscribe to our channel: https://goo.gl/bkDSLj
Check out Catch News for more news: http://www.catchnews.com/
Follow Catch News here -
Facebook:https://bit.ly/2xD3NKZ
Twitter: https://bit.ly/2NG3rhr
Instagram: https://bit.ly/30mh2vE
--------------------------------------------------------------------------------------------
Also, Follow Catch in Hindi: http://hindi.catchnews.com/
Catch is a contemporary new digital platform about the ideas and events shaping the world. It aims to filter and provide news-on-the-run for an impatient new generation. It offers greater insight for influencers and the deeper consumer of news. When opinions are shrill and polarized, we hope to create a middle ground and build bridges. When there is a set thinking, we hope to stand apart and go against the wind. The world is complex, exciting, layered, evolving, always interesting. We hope to be the same.
Lots of videos and lots more in the pipeline. Stay tuned.
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch NewsBy Catch News| 170 views
Bharat Biotech’s 'Covaxin' gets SEC nod for phase 2-3 clinical trials on 2 to 18 year-olds
Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently and has been developed by Bharat Biotech.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Bharat Biotech’s 'Covaxin' gets SEC nod for phase 2-3 clinical trials on 2 to 18 year-oldsBy The Economic Times| 112 views
100 Covaxin sites will shut down as Bharat Biotech unable to provide more doses, says Manish Sisodia
Deputy Chief Minister of Delhi, Manish Sisodia said, 'Bharat Biotech wrote to us that they could not give us more doses, the central government is controlling the supply of the vaccine. I would say exporting 6.6 cr doses was the biggest mistake, We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply’. Listen in.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
100 Covaxin sites will shut down as Bharat Biotech unable to provide more doses, says Manish SisodiaBy The Economic Times| 148 views
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare. Bharat Biotech will conduct trials in 525 healthy volunteers. "In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28," it said.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrsBy The Economic Times| 186 views
Two PSUs enter into pact with Covaxin maker Bharat Biotech to produce Covid-19 vaccines
Two government-owned companies have entered into an agreement with Bharat Biotech to share the vaccine formula in order to manufacture Covid-19 vaccines.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Two PSUs enter into pact with Covaxin maker Bharat Biotech to produce Covid-19 vaccinesBy The Economic Times| 465 views
The central government has asked the Serum Institute of India and Bharat Biotech to lower the price of COVID vaccines, Covishield and Covaxin as India gears up to vaccinate all aged above 18 from May 1, official sources said on Monday.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Centre asks Serum Institute, Bharat Biotech to lower prices of Covishield, Covaxin: Sources
#businessnews#economynews#economictimes#ETMarkets#coronavirus#covid19#covaxin#BharatBiotech#covishield#Covidvaccines#SerumInstituteofIndiaSII
Category:
News
Govt rejects Serum Institute of India’s request to export 50 lakh doses of Covishield vaccine to UK
Amid reports of Covid-19 vaccine shortage across the country, the Modi government has refused to allow Serum Institute of India (SII) to export around 50 lakh doses of Covishield vaccine to the United Kingdom. While rejecting SII’s request, the central government insisted that the local vaccine production be supplied to protect Indians first.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Govt rejects Serum Institute of India’s request to export 50 lakh doses of Covishield vaccine to UKBy The Economic Times| 245 views
Covishield Price Drop : Serum Institute ने कोविशील्ड का घटाया दाम, 300 में मिलेगी कोरोना की वैक्सीन
Serum Institute ने कोविशील्ड का घटाया दाम, राज्यों को अब 300 में मिलेगी कोरोना की वैक्सीन
Visit Us - http://www.inhnews.in/
Follow Us On Twitter - https://twitter.com/inhnewsindia
Our WhatsApp Number - 9993022843
Link - https://youtu.be/XVOd1wWkhx8
Incoming Search Terms,
#COVIDSecondWave #CoronavirusVaccine
COVID-19 Vaccine News,
Corona Vaccine,
Covid-19 vaccination,
Corona Vaccine In India,
COVID-19 Vaccine in India,
COVID-19 vaccination in India,
COVID Second Wave in India,
Corona Second Wave,
Corona Virus Outbreak in India,
Corona Virus in India,
Latest News,
Covishield Price Drop : Serum Institute ने कोविशील्ड का घटाया दाम, 300 में मिलेगी कोरोना की वैक्सीनBy Inh News| 136 views
Serum fixes 'Covishield' prices at Rs 400 per dose for state govts, Rs 600 for private hospitals
Serum Institute of India (SII), the world's largest vaccine maker, on Wednesday announced a price of Rs 600 per dose for COVID vaccine supplies to private hospitals and Rs 400 per dose to state governments. In a statement posted on its Twitter handle, SII said it will address the limited capacity by scaling up the vaccine production over the next two months.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Serum fixes 'Covishield' prices at Rs 400 per dose for state govts, Rs 600 for private hospitalsBy The Economic Times| 453 views
Coronavirus : कोरोनावायरस की तीसरी लहर से Bharat Biotech की 'Covaxin' बचाएगी बच्चों को !
कोरोनावायरस : भारत में कोरोनावायरस संक्रमण की तीसरी लहर इस साल सर्दियों के मौसम यानी नवंबर के अंत और दिसंबर की शुरुआत में आने की संभावना है। हेल्थ एक्सपर्ट्स का कहना है कि यह तीसरी लहर बच्चों के लिए ज़्यादा खतरनाक होगी। इस खबर ने पेरेंट्स की चिंता को बढ़ा दिया था क्योंकि देश में बच्चों के लिए कोरोना वायरस की कोई वैक्सीन अभी उपलब्ध नहीं है। लेकिन इस बीच बड़ी खुशखबरी ये मिल रही है कि जल्द ही 2 साल से 18 साल तक के बच्चों के लिए आने वाले दिन में कोरोना की वैक्सीन मिल सकती है। भारत बायोटेक की कोवैक्सीन जल्द ही बच्चों के लिए भी उपलब्ध हो जाएगी। आधिकारिक सूत्रों ने कहा है कि मंगलवार को सेंट्रल ड्रग्स स्टैंडर्ड कंट्रोल आर्गेनाईजेशन यानी (CDSCO ) की एक विशेष पैनल ने भारत बायोटेक की कोवाक्सिन को 2 से 18 साल की उम्र के ट्रायल के लिए मंजूरी दे दी है। यह ट्रायल विभिन्न जगहों पर 525 बच्चों पर होगा, जिनमें एम्स दिल्ली, एम्स पटना और मेडिट्रिना इंस्टीट्यूट ऑफ मेडिकल साइंसेज, नागपुर शामिल हैं। कोवैक्सीन पूरी तरह से स्वदेशी है, जिसे भारत बायोटेक ने बनाया है। अभी तक यह वैक्सीन 18 साल से ऊपर से लोगों के लिए ही बनाई गई है।
To Subscribe on Youtube:
https://www.youtube.com/user/punjabkesaritv
Follow us on Twitter :
https://twitter.com/punjabkesari
Like us on FB:
https://www.facebook.com/Pkesarionline/
Coronavirus : कोरोनावायरस की तीसरी लहर से Bharat Biotech की 'Covaxin' बचाएगी बच्चों को !By PunjabKesari TV| 375 views
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch News
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch News
Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently and has been developed by Bharat Biotech.
#BharatBiotech #Covaxin #CovidVaccine #catchnews #CatchNewsToday
For more videos, subscribe to our channel: https://goo.gl/bkDSLj
Check out Catch News for more news: http://www.catchnews.com/
Follow Catch News here -
Facebook:https://bit.ly/2xD3NKZ
Twitter: https://bit.ly/2NG3rhr
Instagram: https://bit.ly/30mh2vE
--------------------------------------------------------------------------------------------
Also, Follow Catch in Hindi: http://hindi.catchnews.com/
Catch is a contemporary new digital platform about the ideas and events shaping the world. It aims to filter and provide news-on-the-run for an impatient new generation. It offers greater insight for influencers and the deeper consumer of news. When opinions are shrill and polarized, we hope to create a middle ground and build bridges. When there is a set thinking, we hope to stand apart and go against the wind. The world is complex, exciting, layered, evolving, always interesting. We hope to be the same.
Lots of videos and lots more in the pipeline. Stay tuned.
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch NewsBy Catch News| 170 views
Bharat Biotech’s 'Covaxin' gets SEC nod for phase 2-3 clinical trials on 2 to 18 year-olds
Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently and has been developed by Bharat Biotech.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Bharat Biotech’s 'Covaxin' gets SEC nod for phase 2-3 clinical trials on 2 to 18 year-oldsBy The Economic Times| 112 views
100 Covaxin sites will shut down as Bharat Biotech unable to provide more doses, says Manish Sisodia
Deputy Chief Minister of Delhi, Manish Sisodia said, 'Bharat Biotech wrote to us that they could not give us more doses, the central government is controlling the supply of the vaccine. I would say exporting 6.6 cr doses was the biggest mistake, We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply’. Listen in.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
100 Covaxin sites will shut down as Bharat Biotech unable to provide more doses, says Manish SisodiaBy The Economic Times| 148 views
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare. Bharat Biotech will conduct trials in 525 healthy volunteers. "In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28," it said.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrsBy The Economic Times| 186 views
Two PSUs enter into pact with Covaxin maker Bharat Biotech to produce Covid-19 vaccines
Two government-owned companies have entered into an agreement with Bharat Biotech to share the vaccine formula in order to manufacture Covid-19 vaccines.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Two PSUs enter into pact with Covaxin maker Bharat Biotech to produce Covid-19 vaccinesBy The Economic Times| 465 views
The Economic Times
From priority to allocation criteria: Centre releases revised guidelines for COVID vaccination drive
Govt of India releases revised guidelines for national COVID vaccination program, to be implemented from June 21. "Vaccine doses to be allocated to States/UTs based on population, disease burden & vaccination' progress. Wastage will affect allocation negatively," guidelines say.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
From priority to allocation criteria: Centre releases revised guidelines for COVID vaccination driveBy The Economic Times| 64910 views
Suvendu Adhikari meets HM Amit Shah amid reports of post-poll violence in Bengal
Leader of Opposition in the West Bengal Assembly and BJP MLA Suvendu Adhikari called on Union Home Minister Amit Shah in Delhi amid reports of post-poll violence in Bengal.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Suvendu Adhikari meets HM Amit Shah amid reports of post-poll violence in BengalBy The Economic Times| 1160 views
Uttar Pradesh: 22 patients die during alleged 'mock oxygen drill' at Agra hospital, probe on
22 Covid & non-Covid patients allegedly died following a 'mock oxygen drill' in UP. A viral video purportedly of a hospital owner in Agra has sparked a major controversy. In the video, the man is heard saying that he got oxygen supply from patients snapped for 5 mins. The man, in the video, added that this was part of an experiment to know who all will survive. Reports suggest the video is purportedly of Arinjay Jain, owner of Paras Hospital on NH 2. UP health dept has ordered a probe into the incident after the video went viral.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Uttar Pradesh: 22 patients die during alleged 'mock oxygen drill' at Agra hospital, probe onBy The Economic Times| 1165 views
Govt./PSU
Robotic Process Automation is transforming businesses across the world
Robotic Process Automation enables users to create software robots, or #Bots, that can observe, mimic & execute repetitive, time consuming #Digital #business processes by studying human actions.
Watch the video to know how RPA is transforming #businesses.
#ArtificialIntelligence
Robotic Process Automation is transforming businesses across the worldBy CII| 207603 views
Address by Sh. Rajeev Gupta, Secretary, Youth Affairs at "International Yoga Seminar"
Address by Shri. Rajeev Gupta, Secretary, Youth Affairs, Ministry of Youth Affairs & Sports, at the "International Yoga Seminar" organized by "Shri Ram Chandra Mission" in April, 2016
Watch Address by Sh. Rajeev Gupta, Secretary, Youth Affairs at "International Yoga Seminar" With HD QualityBy Ministry of Youth Affairs| 769078 views
Blatant Violation of model code of conduct in Odisha
Blatant Violation of model code of conduct in Odisha
Watch Blatant Violation of model code of conduct in Odisha With HD QualityBy Dharmendra Pradhan| 818225 views
IRCTC 11
CRPF signed an MoU with the IRCTC on Railway Reserved e-ticketing system
Watch IRCTC 11 With HD QualityBy CRPF India| 1123452 views
ECI Press Briefing
Press briefing of Election Commission of India on completion of 2nd Phase of #LokSabhaElection2019 and State Legislative Assemblies elections.
#PollingDay #DeskKaMahaTyohaar #NoVoterToBeLeftBehind
Watch ECI Press Briefing With HD QualityBy Election Commission of India| 431662 views
Special Briefing on the Visit of President of Maldives to India (August 02, 2022)
Special Briefing on the Visit of President of Maldives to India (August 02, 2022)By Ministry of External Affairs, India| 194307 views
Trending Now
Daily Mirror
Nitish Kumar की जगह Jitan Ram Manjhi को CM बनाएंगे BJP ! Mukesh Sahani | Bihar News | #dblive
Nitish Kumar की जगह Jitan Ram Manjhi को CM बनाएंगे BJP ! Mukesh Sahani | Bihar News | #dblive
#HindiNews | #BreakingNews | #Watch | #video |
Get paid membership : https://www.youtube.com/channel/UCBbpLKJLhIbDd_wX4ubU_Cw/join
DB LIVE APP : https://play.google.com/store/apps/details?id=dblive.tv.news.dblivetv.com
DB LIVE TV : http://dblive.tv/
SUBSCRIBE TO OUR CHANNEL: https://www.youtube.com/channel/UCBbpLKJLhIbDd_wX4ubU_Cw
DESHBANDHU : http://www.deshbandhu.co.in/
FACEBOOK : https://www.facebook.com/DBlivenews/
TWITTER : https://twitter.com/dblive15
ENTERTAINMENT LIVE : https://www.youtube.com/channel/UCyX4qQhpz8WQP2Iu7jzHGFQ
Sports Live : https://www.youtube.com/channel/UCHgCkbxlMRgMrjUtvMmBojg
Nitish Kumar की जगह Jitan Ram Manjhi को CM बनाएंगे BJP ! Mukesh Sahani | Bihar News | #dbliveBy DB Live| 0 views
BJP MLA Ganpat Gaikwad ने Eknath Shinde Shiv Sena Leader Mahesh Gaikwad को थाने के अंदर मारी गोलियां
#ganpatgaikwad #maheshgaikwad #eknathshinde
गोलियों की तड़तड़ाहट... भागते... जान बचाते लोग.... बीजेपी नेता की आंखों में खून सवार... ये वीडियो कहीं और का नहीं बल्कि बीजेपी के नेतृत्व में बनी एकनाथ शिंदे सरकार के महाराष्ट्र राज्य का है... गोलियां मारने वाला कोई और नहीं बल्कि मौजूदा विधायक और बीजेपी का प्रतिष्ठित नेता है... सत्ता की हनक ऐसी कि थाने के अंदर गोलियां दाग रहा है...
Subscribe to our YouTube channel: https://bit.ly/PunjabKesariTV
Also, Watch ►
Latest News & Updates ► https://bit.ly/PunjabKesariTVLatestNews
Latest News On Jammu & Kashmir ► https://bit.ly/JammuKashmirNews
Delhi News Updates | Punjab Kesari TV ► https://bit.ly/LatestDelhiNewsUpdates
Latest Updates On West Bengal ► https://bit.ly/LatestWestBengalNews
Viral Videos | Punjab Kesari TV ► https://bit.ly/LatestViralVideos
Punjab Kesari National | Latest News & Updates ► https://bit.ly/LatestNationalNews
Exclusive Interviews ► https://bit.ly/PunjabKesariTV-ExclusiveInterviews
Russia Ukraine Crisis Live Updates ► https://bit.ly/UkraineRussiaCrisisUpdates
Latest Updates On International News ► https://bit.ly/LatestInternationalNews
Follow us on Twitter: https://twitter.com/punjabkesari
Like us on FB: https://www.facebook.com/Pkesarionline/
BJP MLA Ganpat Gaikwad ने Eknath Shinde Shiv Sena Leader Mahesh Gaikwad को थाने के अंदर मारी गोलियांBy PunjabKesari TV| 0 views
Jummah की नमाज को लेकर Kashi में Police Alert, चप्पे- चप्पे पर Force तैनात
#gyanvapicase #uttarpradesh #varanasi #policealert #jummah #Friday prayers
Jummah की नमाज को लेकर Kashi में Police Alert, चप्पे- चप्पे पर Force तैनात
#gyanvapicase #uttarpradesh #varanasi #policealert #jummah #Friday prayers #pictures #forces deployed #corner #regarding #Gyanvapi complex #policemen #Manduadih police station # in-chargeBharat Upadhyay #patrolled # Bansfatak area #security arrangements #Gyanvapi #Police Commissioner Mutha Ashok Jain #security #arrangements #sensitive places #experience #police #darshan puja started #Vyasji's basement #saint community #officials # Kashi Vidvat Parishad #performed #Gyan Talgriha #Gyan Talgrihnews #Committee #approved # five o'clock aarti # first aarti
Follow Us On:
Facebook : https://www.facebook.com/INDIALNV
Twitter : https://twitter.com/india_lnv
Instagram : https://www.instagram.com/lnv_india/Follow Us On:
Facebook : https://www.facebook.com/INDIALNV
Twitter : https://twitter.com/india_lnv
Instagram : https://www.instagram.com/lnv_india/
Jummah की नमाज को लेकर Kashi में Police Alert, चप्पे- चप्पे पर Force तैनातBy LNV India| 0 views
Dehradun Live | विधानसभा में बोले रहे सीएम पुष्कर सिंह धामी उत्तराखंड विधानसभा सत्र का आगाज
#latestnewsupdates #breakingnews #news #uttrakhand #pushkarsinghdhami #budgetsession #bjp #vidhansabha #news #jantv
Watch JAN TV on :
Tata Play DTH : 1185
Airtel DTH: 355
JIO Fiber: 1384
https://www.youtube.com/jantvindia/live
Make sure you subscribe to our channel and never miss a new video:
https://www.youtube.com/jantvindia
https://www.facebook.com/jantvindia
https://www.instagram.com/jantvindia/
https://twitter.com/JANTV2012
http://www.jantv.in
Jan TV Live | Hindi News LIVE 24X7 | Jan TV Live | Hindi news 24X7 LIVE
Jan TV | Hindi News Jan TV Live | Jan TV News | Jan TV Live
News Credit -VKJ
Dehradun Live | विधानसभा में बोले रहे सीएम पुष्कर सिंह धामी उत्तराखंड विधानसभा सत्र का आगाजBy JANTV RAJASTHAN| 0 views
आज आएगा UP का Budget, Budget पेश करने से पहले होगी Yogi Cabinet की Meeting | UP Budget 2024-25
#UPBudget2024 #YogiAdityanath #SureshKumarKhanna
आज आएगा UP का Budget, Budget पेश करने से पहले होगी Yogi Cabinet की Meeting | UP Budget 2024-25
Subscribe to our YouTube channel: https://bit.ly/PunjabKesariTV
Also, Watch ►
Latest News & Updates ► https://bit.ly/PunjabKesariTVLatestNews
Latest News On Jammu & Kashmir ► https://bit.ly/JammuKashmirNews
Delhi News Updates | Punjab Kesari TV ► https://bit.ly/LatestDelhiNewsUpdates
Latest Updates On West Bengal ► https://bit.ly/LatestWestBengalNews
Viral Videos | Punjab Kesari TV ► https://bit.ly/LatestViralVideos
Punjab Kesari National | Latest News & Updates ► https://bit.ly/LatestNationalNews
Exclusive Interviews ► https://bit.ly/PunjabKesariTV-ExclusiveInterviews
Russia Ukraine Crisis Live Updates ► https://bit.ly/UkraineRussiaCrisisUpdates
Latest Updates On International News ► https://bit.ly/LatestInternationalNews
Follow us on Twitter: https://twitter.com/punjabkesari
Like us on FB: https://www.facebook.com/Pkesarionline/
आज आएगा UP का Budget, Budget पेश करने से पहले होगी Yogi Cabinet की Meeting | UP Budget 2024-25By PunjabKesari TV| 0 views